LeonaBio (LONA) Profit After Tax (2019 - 2026)
LeonaBio (LONA) reported Profit After Tax of -$32.9 million for Q1 2026, down 259.84% year-over-year from $20.6 million in Q1 2025, and up 60.32% quarter-over-quarter from -$82.9 million in Q4 2025.
LeonaBio (LONA) Profit After Tax (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Profit After Tax data on file, last reported at -$32.9 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$32.9 million, down 259.84% year-over-year; the trailing twelve-month figure through Mar 2026 was -$129.4 million (down 62.25% YoY), and the FY2025 annual result was -$105.6 million, down 8.94% from the prior year.
- Profit After Tax grew to -$32.9 million in Q1 2026 per LONA's latest filing, from -$82.9 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$6.6 million in Q3 2025 and troughed at -$82.9 million in Q4 2025.
- A 5-year average of -$26.4 million and a median of -$26.9 million in 2024 frame the typical range for Profit After Tax.
- On a YoY basis, Profit After Tax climbed as much as 77.0% in 2025 and fell as far as 452.62% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$30.1 million in 2022, then rose by 9.46% to -$27.3 million in 2023, then jumped by 45.01% to -$15.0 million in 2024, then slumped by 452.62% to -$82.9 million in 2025, then surged by 60.32% to -$32.9 million in 2026.
- Business Quant data shows LONA's Profit After Tax at -$32.9 million in Q1 2026, -$82.9 million in Q4 2025, and -$6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | -32.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.90 Mn |
| Dec 31, 2025 | -82.91 Mn |
| Sep 30, 2025 | -6.61 Mn |
| Jun 30, 2025 | -6.97 Mn |
| Mar 31, 2025 | -9.14 Mn |
| Dec 31, 2024 | -15.00 Mn |
| Sep 30, 2024 | -28.74 Mn |
| Jun 30, 2024 | -26.86 Mn |
| Mar 31, 2024 | -26.34 Mn |
| Dec 31, 2023 | -27.29 Mn |
| Sep 30, 2023 | -32.97 Mn |
| Jun 30, 2023 | -29.60 Mn |
| Mar 31, 2023 | -27.82 Mn |
| Dec 31, 2022 | -30.14 Mn |
| Sep 30, 2022 | -20.19 Mn |
| Jun 30, 2022 | -24.34 Mn |
| Mar 31, 2022 | -20.98 Mn |
| Dec 31, 2021 | -16.34 Mn |
| Sep 30, 2021 | -15.67 Mn |
| Jun 30, 2021 | -13.97 Mn |